Home / World Marketplace / Archive by category Global Health & Biotech (Page 78)

Archive by category Global Health & Biotech

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation First medical device company to become a corporate champion at the ENTerprise Circle level Mont-Saint-Guibert, Belgium – March 25, 2024, 7:05am CET / 2:05am ET (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a [...]

Philips Convenes the Annual General Meeting of Shareholders 2024

March 22, 2024, Amsterdam, the Netherlands (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959) and Peter Löscher (Austrian, 1957) as members of the [...]

Sandoz Opens New Antibiotic Production Facility in Austria, to Significantly Increase Capacity for Life-saving Medicines

EUR 50m investment in Kundl plant extension emphasizes commitment to serve more patients with critical antibiotics, produced entirely in Europe Additional manufacturing area of 3,000m2 means Kundl can now manufacture 240 million packages per year Represents capacity increase of 20% over 2023 and more than doubling from 2021 output levels Automation and innovative technologies allow production [...]

CARBOGEN AMCIS Announces Successful ANVISA Audit of Its Facility in China

BUBENDORF, Switzerland, March 19, 2024 (Korea Bizwire) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai. Between 6-10th November 2023, a five-day inspection was undertaken, which concluded successfully with no critical [...]

Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain

VALENCIA, Spain, March 19, 2024 (Korea Bizwire) – The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We are thrilled to extend a warm invitation to you for the [...]

SPEVIGO® Approved for Expanded Indications in China and the US

Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue1,2,3,4 In China, SPEVIGO®’s expanded approval adds the reduction of occurrences of GPP in pediatric patients aged 12 and above weighing ≥40 kg, and adults5 The US FDA’s approval expands the use [...]

Leading in Health Technology Innovation: Philips One of the Top Patent Applicants at European Patent Office

Amsterdam, the Netherlands, March 19, 2024 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation, Philips’ extensive global R&D programs and collaborations position the company at the [...]

ResMed’s 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third of respondents are now actively tracking their sleep patterns, and many are adjusting bedtime routines in an effort to improve sleep quality. SAN DIEGO, March 15, [...]

Relation Therapeutics Secures $35 Million of New Seed Financing Led by DCVC and Co-lead NVentures, NVIDIA’s Venture Arm

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm London, March 2024 (Korea Bizwire) – Relation Therapeutics, a biotechnology company at the forefront of leveraging computational and experimental approaches to drug discovery, today announced $35 million in new seed financing, bringing its total seed fundraise to $60 [...]

Sandoz Reports Fourth Quarter 2023 Sales and Full-year 2023 Results

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Strong fourth quarter performance, with net sales1 of USD 2.5 billion, up 10% in constant currencies (up 11% in USD) Full-year 2023 net sales of USD 9.6 billion, up 7% in constant currencies (up 6% in USD) Strong growth across all three regions and double-digit [...]